SCHEMBL5370707

SCHEMBL5370707

OC(CN(CC1CC1)C1CCC(C(O)(C(F)(F)F)C(F)(F)F)CC1)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.40
NR1H3 Q13133 1/20 0.40
SLC6A2 P23975 5/20 0.39
SLC6A4 P31645 5/20 0.39
KDM4E B2RXH2 1/20 0.36
AOC3 Q16853 2/20 0.35
CNR2 P34972 1/20 0.34
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
HIF1A Q16665 1/20 0.32
CETP P11597 1/20 0.31
HSD11B1 P28845 1/20 0.31
PTGIR P43119 1/20 0.31
SLC6A3 Q01959 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5353509 0.81 NR1H2 (0.38) NR1H2NR1H3SLC6A2SLC6A4KDM4E
SCHEMBL5355490 0.80 SLC6A2 (0.44) NR1H2NR1H3SLC6A2SLC6A4MEN1
SCHEMBL1459826 0.71 HSD11B1 (0.55) NR1H2NR1H3SLC6A2SLC6A4CYP2D6
SCHEMBL1461003 0.70 SLC6A2 (0.41) SLC6A2SLC6A4MEN1KMT2ACYP2D6
SCHEMBL1460721 0.70 ESR2 (0.51) NR1H2NR1H3HSD11B1
SCHEMBL1461945 0.69 GRIN2B (0.48) NR1H2NR1H3SLC6A2SLC6A4KDM4E
SCHEMBL1460726 0.68 HSD11B1 (0.39) SLC6A2SLC6A4CYP2D6HSD11B1PTGIR
SCHEMBL1460723 0.67 DRD2 (0.47) NR1H2NR1H3SLC6A2SLC6A4MEN1
SCHEMBL1459859 0.67 PTGDR2 (0.44) SLC6A2SLC6A4MEN1KMT2AHSD11B1
SCHEMBL1198328 0.66 KDM4E (0.46) KDM4EAOC3MEN1KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101087754-B Cyclohexane derivatives HOFFMANN LA ROCHE 2012-01-18 CN claimed
CN-101087754-A Novel cyclohexane derivatives HOFFMANN LA ROCHE (CH) 2007-12-12 CN claimed
US-7253282-B2 Hexafluoroisopropanol substituted cyclohexane derivatives HOFFMAN-LA ROCHE INC. (US) 2007-08-07 US claimed
US-20060135601-A1 Novel hexafluoroisopropanol substituted cyclohexane derivatives HOFFMANN-LA ROCHE INC. 2006-06-22 US claimed
CN-101087754-B Cyclohexane derivatives HOFFMANN LA ROCHE 2012-01-18 CN disclosed
CN-101087754-A Novel cyclohexane derivatives HOFFMANN LA ROCHE (CH) 2007-12-12 CN disclosed
EP-1831158-A1 NOVEL CYCLOHEXANE DERIVATIVES F. Hoffmann-Roche AG (CH) 2007-09-12 EP disclosed
US-7253282-B2 Hexafluoroisopropanol substituted cyclohexane derivatives HOFFMAN-LA ROCHE INC. (US) 2007-08-07 US disclosed
WO-2006066779-A1 NOVEL CYCLOHEXANE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2006-06-29 WO disclosed
US-20060135601-A1 Novel hexafluoroisopropanol substituted cyclohexane derivatives HOFFMANN-LA ROCHE INC. 2006-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135601-A1 Novel hexafluoroisopropanol substituted cyclohexane derivatives NR1H3, NR1H2, NR1I2 NR1H2 2/4885NR1H3 1/4885SLC6A2 3185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.